THESE COPD PATIENTS FOUND ANSWERS AND A NEW WAY FORWARD.

 

For some people, COPD is actually caused by a hereditary condition known as alpha-1. If your healthcare provider confirms a diagnosis of alpha-1, they can recommend a treatment plan that may be right for you.

 

A Former Smoker

One day when working out to exercise videos, Doreen began to struggle. Even though she quit smoking, things just didn’t improve. Bronchitis started to happen like clockwork. Then she was diagnosed with alpha-1.

An Avid Runner

Carla enjoyed running, but she started having difficulty keeping up with friends and experiencing more shortness of breath. One day, after an emergency room visit for a collapsed lung, a healthcare provider diagnosed her with alpha-1. After 30 years of health problems, she finally had an answer and a path forward.

 

Knowing can pave the way to new possibilities.

According to the COPD Foundation and other leading COPD health organizations, if you’ve been diagnosed with COPD, you should learn your risk for alpha-1.1-4 If your healthcare professional confirms a diagnosis of alpha-1, they can tell you about the potential options available to you. There may also be lifestyle changes you can make to help better manage your symptoms.

 

Want to know more about genetic COPD screening?

Sign up to learn more about the free AlphaID At Home Service. We’ll show you how easily AlphaIDTM At Home can help you learn your risk for genetic COPD.

*Talk to your healthcare provider about possible treatment options.
The AlphaID At Home Genetic Health Risk Service, including the kit, is provided for free and may not be billed to patients or their insurers. There is no obligation to purchase or use any product or service offered by any manufacturer.

References

  1. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003 Oct 1;168(7):818-900.
  2. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. GOLD COPD 2021 report.
  3. Sandhaus RA, Turino G, Brantly ML, Campos M, Cross CE, Goodman K, Hogarth DK, Knight SL, Stocks JM, Stoller JK, Strange C, Teckman J. The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult. Chronic Obstr Pulm Dis. 2016 Jun 6;3(3):668-682.
  4. World Health Organization. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Org. 1997;75(5):397-415.